Portfolio · Diagnostic tests

Respiratory Infections

Neoplex™ FluCOVID Detection Kit

REF

9416

Description

Real time PCR test with retrotranscription included for the detection of SARS-CoV-2 (2019-nCoV), Influenza A and B in respiratory samples

Packaging

96 test

Certification

Respiratory infections can be viral and/or bacterial and may present non-specific symptoms. Therefore, a diagnostic tool enables to determine quickly the cause of infection is essential for rapid intervention and a correct therapy. Moreover, syndromic panels are indispensable in respiratory diseases, which are usually seasonal, to control and stop any eventual outbreaks.

Summary

Technology

Multiplexing technology

Target

  • SARS-CoV-2
  • Influenza A Virus (Flu A)
  • Influenza B Virus (Flu B)

Mastermix number

1

Internal control

Exogenous

UDG

Yes

Fluorophores

  • FAM
  • ROX/Cal Red 610
  • JOE/VIC
  • Cy5

Limit of Detection (LoD)

See technical data sheet

Analytical specificity

A wide range of pathogens was used to test the assay. No cross-reactivity was found.

Diagnostic sensitivity

100 % for all pathogens

Diagnostic specificity

100 % SARS-CoV-2, 98.23 % Flu A, 99.18 % Flu B

Riproducibility

100 %

Specimen

  • Nasopharyngeal swab
  • Oropharyngeal swab
  • Sputum

Validated thermalcyclers

  • Applied Biosystems™ 7500 Real-time PCR Instrument system (Thermo Fisher Scientific)
  • CFX96™ Real-time PCR detection system (Bio-Rad)

Software

NeoPlex Viewer/Easy-NAT

Explore the product portfolio
Catalog

Information Request

Fill out the form and send us your request.
Sarà nostra cura risponderti al più presto.

"*" indicates required fields

Privacy*
I have read the specific Information on the protection of personal data